Last updated: August 24, 2023
Sponsor: Samsung Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pancreatic Cancer
Liver Cancer
Gall Bladder Disorders
Treatment
Measurement of triceps skinfold thickness
Clinical Study ID
NCT03637569
SMC 2018-04-087-001
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Newly diagnosed pancreatic, bile duct or gallbladder cancer patients, undergoingtherapeutic management (including surgery, chemotherapy or palliative care).
- Age above 18 years old
Exclusion
Exclusion Criteria:
- Other malignant disease
- Underlying intestinal disease that cause absorprtion disorder
- Underlying psychiatric disorder such as eating disorder (bulimia, anorexia)
Study Design
Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Measurement of triceps skinfold thickness
Phase:
Study Start date:
April 01, 2018
Estimated Completion Date:
December 31, 2026
Study Description
Connect with a study center
Samsung Medical Center
Seoul,
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.